- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Garenoxacin is an antibiotic used to treat a variety of bacterial infections. It belongs to the fluoroquinolone class of antibiotics, which are used to treat a wide range of bacterial infections. Garenoxacin is used to treat infections of the respiratory tract, urinary tract, skin, and soft tissue. It is also used to treat certain types of pneumonia and other infections caused by certain bacteria. Garenoxacin is generally well tolerated and has a low risk of side effects.
The market for Garenoxacin is highly competitive, with many companies offering the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, and Sanofi. Other companies in the market include Daiichi Sankyo, Takeda Pharmaceuticals, and Johnson & Johnson. Show Less Read more